Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Self-monitoring during use should note any new lumps, bumps, skin changes, unexplained weight loss, fatigue, or other symptoms that could potentially indicate cancer development
This compound must not be used in a manner that contravenes any applicable sports anti-doping regulation
This activates GLP-1 receptors in your body, leading to an increase in the production of insulin, which helps move glucose into your cells, where its used for energy, Dr
Jalil JE, Gabrielli L, Ocaranza MP, et al
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
